Yep. Not even the same clinical indication or endpoints. I don’t think Advanz Pharma are risking US$213 million either. So just waiting now. I think we have discussed everything we possibly can. Maybe another deal soon & Vifor/CSL not out of the question.
My Neighbours are obviously having an “I didn’t get to go to Tay Tay Party” with a whole lot of kids on the Mike…pretty cute, but sounds terrible but I totally get it.
https://m.youtube.com/watch?v=oA2G-y7ySnI
Ann: Application for quotation of securities - DXB, page-151
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add DXB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
44.3¢ |
Change
-0.003(0.56%) |
Mkt cap ! $239.5M | |||
| Open | High | Low | Value | Volume |
| 44.5¢ | 44.5¢ | 43.0¢ | $131.4K | 301.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 14551 | 44.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 44.5¢ | 55580 | 6 |
View Market Depth
| Last trade - 10.59am 20/08/2024 (20 minute delay) ? |
| DXB (ASX) Chart |